Skip to main content

Table 2 Results of meta-analysis

From: Analysis of the efficacy of subclinical doses of esketamine in combination with propofol in non-intubated general anesthesia procedures - a systematic review and meta-analysis

Outcome indicators

Included study

Heterogeneity test results

Effect model

Results of meat analysis

I2 value(%)

P value

WMD, SMD or RR(95%CI)

P value

HR

11

91

P < 0.00001

Random

3.27(0.66,5.87)

0.01

MAP

6

88

P < 0.00001

Random

9.68(6.13,13.24)

P < 0.00001

SBP

5

78

P = 0.0010

Random

5.42(2.11,8.73)

P = 0.001

DBP

5

80

P = 0.0004

Random

4.02(1.15,6.88)

P = 0.006

propofol dosage

4

95

P < 0.00001

Random

-1.39(-2.45,-0.33)

P = 0.01

wake-up time

7

83

P < 0.00001

Random

-0.55(-1.29,0.19)

P = 0.14

hypotension

8

21

P = 0.26

Fixed

0.30(0.20,0.45)

P < 0.00001

bradycardia

5

0

P = 0.45

Fixed

0.33(0.14,0.77)

P = 0.01

hypoxemia and apnea

11

55

P = 0.01

Random

0.45(0.23,0.89)

P = 0.02

nausea and vomiting

7

0

P = 0.65

Fixed

0.84(0.43,1.67)

P = 0.63

headache and dizziness

5

36

P = 0.18

Fixed

1.57(0.98,2.50)

P = 0.06

injection pain

5

46

P = 0.12

Fixed

0.28(0.13,0.60)

P = 0.001

intraoperative cough

5

38

P = 0.17

Fixed

0.62(0.50,0.77)

P < 0.0001

intraoperative body movements

7

75

P = 0.0005

Random

0.48(0.29,0.81)

P = 0.006

neuropsychiatric symptoms

3

0

P = 0.38

Fixed

1.05(0.28,3.93)

P = 0.94

total incidence of adverse reactions

13

74

P < 0.00001

Random

0.52(0.39,0.70)

P < 0.0001